Skip to main content
Signal8

Biomind Labs Inc. (BMNDF)

Biomind Labs Inc. operates as a biotechnology firm dedicated to advancing innovative pharmaceutical therapies and sophisticated nanotech drug delivery mechanisms, primarily addressing a range of psychiatric and neurological disorders. Among its leading pipeline assets, BMND01 is currently in Phase II clinical trials for treating depression. Another key candidate, BMND08, a derivative of 5-Methoxy-N,N-dimethyltryptamine, is also in Phase II trials, addressing depression and anxiety specifically in patients experiencing cognitive decline associated with Alzheimer's disease. The company's broader development portfolio includes early-stage and preclinical candidates such as BMND02 for fibromyalgia, BMND03 for substance use disorders, BMND05 for persistent pain management, BMND06 for inflammatory conditions, and BMND07 for severe clinical depression. Biomind Labs Inc. maintains its headquarters in Canelones, Uruguay.

Sector: Biotechnology

Industry: Biotechnology

Biomind Labs Inc. logo

Biomind Labs Inc.

OTC:BMNDFHealthcare
-13.95%$0.2153
CLOSED
Mkt Cap$16.7M
EV$17.43M
Float49.41M
O/S77.57M
VOL250 sh
$ Vol$54
RVOL0.22×
Inst Own-
SI<0.1%
Net Cash/Sh-$0.01
Dilution
Biomind Labs Inc. logoOTC:BMNDFClosed$0.2153-13.95%
Financials Summary
Revenue$0
Net Income-$865K
Total Assets$36
Free Cash Flow-$69K
Debt & Equity
Total Debt$728K
Total Equity-$1.74M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:32.5Reverse split
    Jul 30, 202132.5 shares → 1
Balance Sheet Details
Assets$36
Liabilities$1.74M
Accounts Receivable$0
Accounts Payable$390K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
Revenue$0$0$0$0$0$3K$21K$404K$959K$324K$428K$5M$2.42M$11.37M$5.93M-$870K$4.4M$68K$10.53M$371K$5K
YoY Growth------87.6%-94.8%-57.9%195.8%-24.4%-91.4%106.7%-78.7%91.8%-781.6%-119.8%6368.0%-99.4%2733.5%8065.4%-
Cost of Revenue$2K$8K$15K$42K$28K$0$0$0$0$0$0$264K$0$0$0$0$0$0$0$0$0
Gross Profit-$2K-$8K-$15K-$42K-$28K$3K$21K$404K$959K$324K$428K$4.73M$0$0$0$0$0$0$0$0$0
Gross Margin-----100.0%100.0%100.0%100.0%100.0%100.0%94.7%---------
Research and Development$0$16K$313K$574K$571K$35.84M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Selling, General, and Administrative$859K$379K$682K$2.32M$2.83M$845K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other$0$0$0$561$396-$36.49M$301K$1.98M$2.51M$1.15M$2M$5.2M-$2.14M$10.33M$2.04M-$2.46M$858K$1.99M$7.24M$1.45M$47K
Total Operating Expenses$859K$396K$994K$2.89M$3.4M$193K$301K$1.98M$2.51M$1.15M$2M$5.2M-$2.14M$10.33M$2.04M-$2.46M$858K$1.99M$7.24M$1.45M$47K
Operating Income (EBIT)-$861K-$396K-$976K-$2.89M-$3.4M-$190K-$280K-$1.59M-$1.56M-$834K-$1.57M-$470K$4.56M$1.04M$3.85M$1.43M$1.48M-$7.77M-$2.72M-$1.46M-$43K
Operating Margin------7343.1%-1338.0%-393.8%-162.6%-257.4%-366.3%-9.4%188.5%9.1%64.9%-163.8%33.6%-11422.2%-25.9%-393.1%-934.6%
Interest Expense$70K$31K$164K$1K$4K$0$0$0$0$0$0$0$0$1K$33K$110K$169K$1.49M$1.81M$6K$0
Interest Income$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)-$4K$135K-$216K-$95K-$933K$0-$84K$455K$0-$37K$701K$210K-$585K$135K$4.87M-$7.37M-$5.59M-$5.9M$666K-$32K$0
Income Before Tax (EBT)-$865K-$260K-$1.19M-$2.99M-$4.33M-$190K-$364K-$1.14M-$1.56M-$871K-$868K-$260K$3.97M$1.17M$8.71M-$5.95M-$4.11M-$13.67M-$2.06M-$1.49M-$43K
Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0$0$0$11K$100K$502K-$1.13M-$659K$0$0
Net Income-$865K-$260K-$1.21M-$2.99M-$4.33M-$190K-$364K-$1.14M-$3.75M-$615K-$1.37M-$260K$3.97M$1.17M$8.7M-$6.09M-$4.59M-$11.63M$17K-$1.49M-$43K
Net Income Margin------7341.6%-1739.4%-281.1%-390.6%-189.8%-320.5%-5.2%164.3%10.3%146.7%699.8%-104.3%-17093.6%0.2%-401.7%-934.6%
Supplementary Data
EPS-0.01-0.00-0.02-0.04-0.06-0.02-0.04-0.12-0.02-0.00-0.01-0.000.010.000.03-0.03-0.02-0.060.00-0.02-0.01
Diluted EPS-0.01-0.00-0.02-0.04-0.06-0.02-0.04-0.12-0.02-0.00-0.01-0.000.010.000.03-0.03-0.02-0.060.00-0.02-0.01
Weighted Average OS77.57M76.15M74.76M74.76M72.06M9.60M9.60M9.22M173.73M148.26M148.26M204.80M342.94M342.94M342.94M203.69M203.69M203.69M203.69M64.44M5.90M
EBITDA-$859K-$396K-$1.03M-$2.89M-$3.4M$36.49M-$192K-$1.12M-$1.55M-$866K-$867K-$260K$3.97M$1.17M$8.72M-$5.89M-$4.05M-$13.65M-$1.22M-$1.49M-$43K
EBITDA Margin-----1410088.2%-918.1%-277.4%-162.0%-267.3%-202.4%-5.2%164.3%10.3%147.0%676.9%-92.0%-20065.3%-11.6%-401.7%-934.6%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Assets
Current Assets
Cash and Cash Equivalents$36$147$24K$26K$2.27M$82K$334K$1.56M$4.64M$1.17M$2.17M
Short-Term Investments$0$0$125$0$0$0$0$0$1.36M$0$0
Cash and Short-Term Investments$36$147$24K$26K$2.27M$0$334K$1.56M$5.99M$1.17M$2.17M
Accounts Receivable$0$0$0$0$0$0$25K$0$74K$67K$56K
Inventory$0$0$0$0$0$0$360K$0$6.07M$0$2.23M
Other Current Assets$0$0$0$0$0$0-$360K-$1.56M-$6.07M-$1.23M-$2.23M
Total Current Assets$36$21K$45K$45K$2.44M$30K$360K$1.56M$6.07M$1.23M$2.23M
Long-Term Assets
Property, Plant & Equipment Net$0$20K$29K$44K$88K$0$0$0$16K$20K$14K
Goodwill$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$15.9M$14.93M
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$6K$11K$12K$11.23M$63K$82K
Total Long-Term Assets$0$20K$29K$44K$88K$6K$11K$12K$11.25M$15.98M$15.03M
Other Assets$0$0$149$0$0$52K$0$0$0$0$0
Total Assets$36$41K$74K$89K$2.53M$88K$371K$1.57M$17.32M$17.22M$17.26M
Liabilities
Current Liabilities
Accounts Payable$390K$447K$561K$329K$290K$26K$0$0$0$0$0
Short-Term Debt$728K$671K$736K$0$0$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0-$289$0$0$0$0$0$0
Other Current Liabilities$617$224K$210K$0$289$0$0$0$0$0$0
Total Current Liabilities$2K$1.34M$1.51M$337K$325K$218K$0$0$0$0$0
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$62K$52K$259K$204K$207K$265K
Total Long-Term Liabilities$0$0$0$0$10K$62K$52K$259K$204K$207K$265K
Other Liabilities$0$0$0$0$0-$218K$0$0$0$0$0
Total Liabilities$1.74M$1.34M$1.51M$337K$335K$62K$52K$259K$204K$207K$265K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$1$0$0$0
Common Stock$11.45M$11.45M$11.05M$11.1M$11.1M$1.14M$1.22M$1.86M$16M$11.39M$10.99M
Retained Earnings-$15.74M-$14.88M-$14.55M-$13.43M-$10.45M-$11.76M-$11.36M-$10.44M-$11.04M-$6.82M-$5.99M
Comprehensive Income & Other$2.55M$2.14M$2.08M$2.08M$1.54M-$72K-$71K-$106K-$259K$500K$705K
Other Stockholders' Equity$2.55M$2.14M$2.08M$2.08M$1.54M$10.65M$10.46M$9.89M$10.56M$10.5M$10.11M
Total Equity-$1.74M-$1.3M-$1.42M-$248K$2.19M$26K$319K$1.31M$15.52M$15.06M$15.11M
Minority Interest$0$0$0$0$0$0$0$0$1.59M$1.95M$1.88M
Total Liabilities and Equity$36$41K$82K$89K$2.53M$88K$371K$1.57M$15.72M$15.27M$15.38M
Supplementary Data
Total Debt$728K$671K$736K$8K$45K$0$0$0$0$0$0
Net Debt$728$671K$711K-$18K-$2.23M-$82K-$334K-$1.56M-$4.64M-$1.17M-$2.17M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Operating Activities
Net Income-$865K-$260K-$1.21M-$2.99M-$4.33M-$190K-$364K-$1.13M-$1.56M-$615K-$1.37M
Depreciation & Amortization$2K$9K$15K$44K$28K$36.68M$0$15K$6K$5K$233
Deferred Income Tax$0$0$0$49K$64K$0$0$0$0$0$0
Stock-Based Compensation$0$0$8K$554K$1.38M$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$31K-$24K$121K-$5K$13K-$131K
  Inventory$0$0$0$0$0$178$0$0$0$0$0
  Accounts Payable$0$0$0$0$0$9K-$221K$72K-$17K-$67K-$133K
  Other Working Capital$327K$47K$229K$186K-$104K-$178$0$0$0-$0$0
Total Working Capital Change$327K$47K$229K$186K-$104K$40K-$245K$193K-$23K-$55K-$264K
Other Non-Cash Items$467K-$150K$196K$1K$840K-$36.68M$0-$46K$190K-$450K$2.35M
Net Cash from Operating-$69K-$354K-$766K-$2.15M-$2.12M-$150K-$608K-$810K-$1.39M-$1.12M$446K
Investing Activities
Capital Expenditures$0$0$0$0-$45K$0$0$0$0-$11K-$14K
Acquisitions$0$0$0$0$250$0$0$11.41M$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0-$1.42M$0-$12.87M
Sales of Investments$0$0$0$0$0$0$0$1.26M$2.41M$23K$0
Other Investing Activities$0$0$0$0$0$0$0$0$0$0$487K
Net Cash from Investing$0$0$0$0-$44K$0$0$12.67M$995K$12K-$12.4M
Financing Activities
Debt Repaid-$88K-$307K-$762K$39K$30K------
Common Stock Issuance$0-$5K$0$0$4.5M$0$0$0$3.84M$0$0
Common Stock Repurchases$0$0$0$0$0$0$0-$31K-$35K$0$0
Dividends Paid$0$0$0$0$0-$108K-$741K-$12.78M$0$0$0
Other Financing Activities$0-$245-$22K$0$0$0$0-$1.63M$0$0$1.84M
Net Cash from Financing$88K$302K$762K-$39K$4.47M-$108K-$741K-$14.44M$3.81M$0$1.84M
Forex Effect-$19K$28K$2K-$58K-$30K$6K$0$0$0$0$0
Net Change in Cash-$110-$24K-$2K-$2.25M$2.27M-$252K-$1.23M-$3.07M$3.47M-$1.1M-$10.11M
Supplementary Data
Operating Cash Flow-$69K-$354K-$766K-$2.15M-$2.12M-$150K-$608K-$810K-$1.39M-$1.12M$446K
Capital Expenditure$0$0$0$0-$45K$0$0$0$0-$11K-$14K
Free Cash Flow-$69K-$354K-$766K-$2.15M-$2.17M-$150K-$608K-$810K-$1.39M-$1.13M$432K
Cash at Beginning$147$24K$26K$2.27M$82K$334K$1.56M$4.64M$1.17M$2.27M$12.28M
Cash at End$36$147$24K$26K$2.27M$82K$334K$1.56M$4.64M$1.17M$2.17M